Patients with psoriasis face slightly increased risk for Alzheimer disease

  • Kim M & al.
  • Sci Rep
  • 15 Apr 2020

  • curated by Brian Richardson, PhD
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Psoriasis is associated with a slightly increased incidence of Alzheimer disease (AD), according to a national database review.

Why this matters

  • This correlation suggests that increased screening for AD in patients with psoriasis may be justified.

Key results

  • 2.11% of patients with psoriasis and 1.87% of control participants were diagnosed with AD.
  • Psoriasis was associated with a slightly increased risk for AD:
    • HR, 1.09 (P<.0001>
  • In subgroup analysis, risk for AD was increased in those who were not receiving systemic therapy vs those who were:
    • HR, 1.098 (95% CI, 1.075-1.121) without systemic therapy.
    • HR, 0.988 (95% CI, 0.896-1.086) with systemic therapy.

Study design

  • Data for 535,927 patients with psoriasis and 2,679,635 age- and sex-matched control individuals from the Korean National Health Insurance System database were analyzed for incident AD.
  • Funding: Institute of Clinical Medicine Research in the Yeouido St. Mary’s Hospital, Catholic University of Korea.

Limitations

  • Observational study of large database.
  • No causation established.